MedTrace Logo

PROgastrine COlon DEpistage

NCT03775473 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 260

Last updated 2022-01-27

No results posted yet for this study

Summary

Dosage of progastrin in asymptomatic person participating in colon cancer screening

Conditions

  • Colon Cancer Screening
  • Healthy Person

Interventions

DIAGNOSTIC_TEST

progastrin

PROCODE is an interventional study of category 2 (non-medicinal product), with a minimal risks and restrictions, involving only one blood drawn at the screening of colon cancer.

Sponsors & Collaborators

  • Centre Hospitalier Princesse Grace

    collaborator OTHER

  • ECS-Progastrin SA

    lead INDUSTRY

Principal Investigators

  • Georges GARNIER · Centre Hospitalier Princesse Grace

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
50 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-02-07
Primary Completion
2021-02-05
Completion
2021-12-17

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03775473 on ClinicalTrials.gov